Thus, protection of IFNAR1 from degradation in the presence of IFNs is proposed to be a new therapeutic means to enhance the efficacy of type I IFNs for the treatment of tumorigenesis, which requires higher doses of type I IFNs than those used for the treatment of viral diseases (28). The gene discussed is IFNAR1; the disease is viral load.